Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...

A Chinese research team has uncovered a previously unknown gut-joint axis mechanism that drives osteoarthritis, ...

The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Studies show that GLP-1 agonists can help patients lose 5-15% of their body weight when combined with diet and exercise.

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

In a plenary session at the annual American Academy of Neurology meeting, Paul Edison, MD, PhD, of Imperial College London in ...

FAMOUS comedian Jo Koy was in another big venue, the SM Mall of Asia Arena, on Sunday - only this time, he wasn't taking the stage. Instead, the proud Filipino was watching from the front row, as ...

The therapeutic potential of targeting glucagon-like peptide-1 (GLP-1 ... more potent and longer-lasting GLP-1-based therapies as well as the discovery of mechanism related new targets. What are ...

The medication is a glucagon-like peptide-1 receptor agonist that works by controlling blood sugar levels. The drug’s active ingredient is called dulaglutide. Other glucagon-like peptide-1 ...

Edited by Lily Jan, Howard Hughes Medical Institute–University of California San Francisco, San Francisco, CA; received August 17, 2024; accepted March 3, 2025 ...